Search Browse Earnings

Checkpoint Therapeutics, Inc.

Pharmaceutical Preparations·WALTHAM, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Oliviero James F Iii

CFO

Gray William Garrett

Revenue

$103,000

-46.4% YoY

FY 2024

Adj. EBITDA

—

Net Income

-$51.8M

-50336.9% margin

FY 2024

EPS (Diluted)

-$3.17

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$4.9M

FY 2024

Total Debt

$2.5M

FY 2016

Net Cash

$2.5M

FY 2016

Enterprise Value

—

Debt / EBITDA

—

EV / EBITDA

—

Employees

—